We cultured Plasmodium falciparum parasites from 98 Ugandan children with malaria and determined the complexity of infection (COI) on the basis of msp-2 polymorphisms daily for 9 days. The mean COI decreased during culture from 1.73 to 1.56. New strains appeared after day 0 in 20 cultures. Strains disappeared after day 0 in 56% of 45 cultures that were initially mixed; persisting strains more commonly had wild-type dhfr (C59) and dhps (K540) sequences and mutant pfmdr1 (86Y) sequences. Thus, initial genotypes offer an imperfect representation of clinical COI. Loss of strains in culture may be due to diminished fitness of some drug-resistant strains.
Techniques to culture erythrocytic stages of Plasmodium falciparum have been available for Ͼ30 years [1] . The study of cultureadapted strains is essential for much laboratory research on malaria; these strains have typically been cultured for months to years before analysis. Cultures of fresh parasites are widely used to study the in vitro drug sensitivity of infecting parasites and to search for associations between parasite features and clinical outcomes. However, P. falciparum infections are commonly polyclonal in many areas, and, because not all parasites successfully grow in culture, it is unclear how well in vitro culture represents the complexity of clinical infections.
In high-transmission areas, such as sub-Saharan Africa, the complexity of P. falciparum infections is typically high; for example, the complexity of infection (COI) was measured at 2.2-4.4 per subject by single time point assessments of individuals with uncomplicated malaria at 7 sites with varied transmission intensity in Uganda [2] and at 5.2-6.8 after intensive evaluation (at 8 time points) of asymptomatic parasitemic children in Senegal [3] . COI is typically measured by assessment of the diversity of highly polymorphic P. falciparum genes, most commonly the gene encoding merozoite surface protein 2 (msp-2). To characterize changes in COI during short-term culture of P. falciparum, we cultured parasites from children with malaria in Kampala, Uganda, and characterized COI on the basis of msp-2 polymorphisms in 98 samples for which culture was maintained for 9 days.
Methods. Samples were collected from a cohort of children in the Mulago III Parish of Kampala enrolled in a longitudinal drug efficacy comparison [4] . At the time of new diagnosis of malaria, blood was spotted onto filter paper (Whatman 3MM), collected in an EDTA tube, and transported within 1 h to our laboratory. Giemsa-stained thin blood smears were examined, and if P. falciparum infection and the lack of other plasmodial species were confirmed, culture was initiated as follows: blood was centrifuged, plasma and buffy coat were removed, and the erythrocyte pellet was washed with RPMI 1640 medium supplemented with 25 mmol/L HEPES, 0.2% NaHCO 3 , 0.1 mmol/L hypoxanthine, and 0.25%-0.5% Albumax II serum substitute. Washed erythrocyte pellets (200 L) were used to inoculate cultures in the same medium at 2% hematocrit in 10-mL sterile flasks. Parasites were then placed in a candle jar or in 5% CO 2 at 37°C. Every 24 h, Giemsa-stained smears of cultures were examined, blood was spotted onto filter paper, and culture medium (prepared fresh at least every 2 weeks) was replaced. All cultures in which parasites remained for 9 days were considered in this analysis.
For analysis of COI, parasite DNA was extracted from filter paper using Chelex 100 resin, and a variant-specific nested polymerase chain reaction (PCR) protocol was used to amplify either the 3D7 or FC27 variants of the msp-2 gene, as described elsewhere [5] . PCR products were resolved on agarose gels, and the sizes of products were compared with standards and between days on densitometric digitized gel images analyzed by GelCompar II software (Applied Maths). Strains from different days were considered identical if estimated fragment lengths were within 15 bp.
Polymorphisms in individual loci of 3 genes, dhfr C59R, dhps K540E, and pfmdr1 N86Y, were determined by nested PCR of relevant portions of the genes followed by sequence-specific restriction endonuclease digestion [6, 7] , resolution of digestion products by agarose gel electrophoresis, and analysis of densitometric digitized gel images using GelCompar II software. For statistical analysis, we used a 1-sample test of proportions to test the null hypothesis that equal proportions of mutant and wildtype parasites would be selected in culture.
Results and discussion. We placed into culture 211 samples from children in Kampala (aged 1-0 years at the time of study enrollment) with acute malaria. Of the samples collected, 98 were successfully cultured for 9 days. Other samples were not maintained owing to failure of parasites to survive for 9 days (100 cultures) or bacterial contamination (13 cultures). Parasite density at diagnosis was greater in samples that successfully grew for 9 days (mean, 30,400 parasites/L) than in those that did not (mean, 11,500 parasites/L). COI was assessed daily on the basis of the analysis of polymorphic regions of msp-2. Of the 98 samples, for 53 only a single genotype was detected at the time of the initiation of culture (day 0). The mean COI on day 0 was 1.73 (95% confidence interval [CI], 1.56 -1.92); the COI was stable for the first 4 days of culture and then decreased gradually to 1.56 (95% CI, 1.40 -1.73) on day 8 ( figure 1A ).
The measured COI was lower than that determined in a number of other areas of Africa [2, 3] and was also lower than the COI of 2.88 that we measured in children in Kampala in another study [8] . The relatively low COI reflects the fact that Kampala has relatively low transmission for sub-Saharan Africa. In addition, our genotyping was based on only a single polymorphic gene, likely underestimating the true diversity of cultured parasites. Finally, study children had benefited from prompt treatment of all malaria episodes for 6 months before evaluation for this study, likely decreasing parasite prevalence. To gain insight into the sensitivity of single time point assessment of COI, we followed the appearance of new strains after day 0. Strains not present on day 0 were first identified on days 1-5; 26 new strains were identified in 20 cultures ( figure 1B) . On the basis of these results, the day 0 genotype understated the true COI in 20% of samples. The appearance of new strains identifies limitations in the sensitivity of a single msp-2 assessment. Prior studies have shown changes in parasite genotypes within hours after treatment in France [9] , quite constant genotypes in Sweden [10] , and a moderate level of change in genotype between days 0 and 1 in Tanzania [11] . In Tanzania, ϳ20% of recurrent outcomes in a treatment efficacy trial were changed (from new infection to recrudescence) by considering both day 0 and 1 rather than only day 0 genotypes as the baseline for comparison with recurrent parasites. Our results similarly indicate a substantial underrepresentation of the true complexity of a malarial infection when only a single day 0 genotype is assessed. Because all parasites that appear in culture after day 0 must necessarily have been present initially, our results identify the minimum number of circulating strains that were missed by genotyping at a single time point on day 0.
We were also interested in the loss of strains after day 0. In 25 of the 45 cultures that were polyclonal on day 0, some strains disappeared during 9 days of culture (figure 2); a total of 32 strains disappeared. We examined the possibility that parasite fitness, considered here as the ability of a parasite to survive in culture, played a role in the disappearance of certain strains. Fitness might be diminished in drug-resistant parasites, as appears to be the case with chloroquine-resistant strains, which were replaced by wild-type parasites after drug pressure was removed in China and Malawi [12] . We therefore evaluated 3 resistance-mediating polymorphisms in mixed cultures that subsequently became monoclonal (within our limits of detection): the key mediators of antifolate resistance in East Africa, dhfr C59R and dhps K540E [13] , and a mediator of responses to a number of antimalarials, pfmdr1 N86Y [14] . Of 12 cultures that had mixed genotypes at dhfr 59 on day 0, 5 were subsequently monoclonal on day 8 (4 C59 and 1 59R). Of 21 cultures that were mixed at dhps 540 on day 0, 2 were subsequently monoclonal on day 8, both pure wild type (K540). Thus, for the mutations that mediate sulfadoxine-pyrimethamine resistance, when cultures became monoclonal, wild-type parasites persisted in 6 of 7 instances. With the small available sample size, results did not differ significantly from a random distribution of alleles (P ϭ .18 and P ϭ .16 for the selection of C59 and K540, respectively).
Of 19 cultures that were mixed at pfmdr1 86 on day 0, 5 were subsequently monoclonal on day 8, all with the 86Y genotype, a significant selection for 86Y in culture (P ϭ .03). Of note, the pfmdr1 86Y genotype, which is typically classified as mutant, actually leads to improved activity of a number of drugs, including mefloquine, quinine, and artemisinins [15] . Thus, it is plausible that all 3 studied polymorphisms may have come at some cost to fitness, as suggested by our results showing parasites with dhfr C59, dhps K540, and pfmdr1 86Y outcompeting those with other sequences at these loci in culture. Of note, an important factor not considered in our in vitro experiments is the impact of circulating drugs on the removal of drug-sensitive parasites.
Our results offer, to our knowledge, the first assessment of COI during culture of freshly isolated malarial parasites. They have a number of ramifications. First, we confirm the findings of studies from other areas showing that COI is underestimated by a single characterization on day 0, presumably because of limits in sensitivity for low-abundance strains. This observation is particularly relevant for drug efficacy trials. In this case, strains missed on day 0 and seen after treatment will be misclassified as new infections, thus understating levels of drug resistance. In our study, 26 strains appeared only after day 0 (mostly on day 1), indicating that genotyping using a combination of days 0 and 1 patterns as baseline, as has been suggested previously [11] , might make assessments of recrudescence rates more reliable, albeit at the cost of added complexity in trial design. Second, we characterize the dynamics of parasite complexity in fresh cultures. Many samples did not survive in culture for 9 days, and surviving cultures showed a gradual decrease in COI over time. Thus, parasites studied after culture adaptation represent only a subset of those infecting a patient, and inferences regarding associations between cultured parasites and clinical outcomes must consider For each culture, DNA was extracted daily, the 3D7 and FC27 alleles of msp-2 were amplified, and products were resolved by agarose gel electrophoresis. Controls included no DNA (Neg) and DNA from laboratory strains known to express the 3D7 (3D7) or FC27 (HB3) allele. Sizes were compared on the basis of 50-bp markers (M). The results shown demonstrate a culture with an initial complexity of infection (COI) of 4, with a loss of two 3D7 strains after day 2 (A), and a culture with an initial COI of 1, with the appearance of an additional 3D7 strain on day 5 (B).
the possibility that some disease-mediating strains may be lost before analysis. Third, we offer the intriguing possibility that loss of some strains in culture is due to a relative disadvantage of drug-resistant parasites. Thus, evaluation of parasites after culture adaptation may include a bias toward drug-sensitive parasites.
Our study had some limitations. First, it was limited to parasites that were successfully cultured for 9 days. For approximately half of our cultures, no strain survived for 9 days. Factors leading to rapid loss of these strains were not considered. Changes in techniques, including use of a defined gas mixture, increase in concentration of the serum substitute, or use of human serum, might have improved survival in culture. Second, we used only a single marker, msp-2, to distinguish parasite strains. The msp-2 marker has been shown to provide reasonable discrimination of P. falciparum strains in Kampala [5] , although consideration of additional strains would likely increase estimates of COI. Third, we considered genotypes based on amplification of parasite DNA from dried blood spots. This technique matched that used in most clinical trials but might not be as sensitive as amplification of DNA purified from whole blood, again potentially underestimating COI. Fourth, for associations between parasite polymorphisms and survival in culture, our sample sizes were small, because relatively few cultures underwent changes in population structure, and our knowledge of the impact of polymorphisms on parasite fitness is incomplete. Despite these limitations, our results offer insight into the dynamics of freshly prepared P. falciparum cultures. In particular, our findings suggest potential limitations in both the use of a single time point assessment of COI as a baseline for drug efficacy determination and the reliability of associations between parasite genotypes and clinical outcomes that are based on assessment of stably cultured parasites.
